| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Harald S. Hansen | Q43076141 |
| Thi Ai Diep | Q59468346 | ||
| P2093 | author name string | Harald S Hansen | |
| Thi Ai Diep | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anandamide | Q410228 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 553-560 | |
| P577 | publication date | 2009-05-04 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | N-acylethanolamines, anandamide and food intake | |
| P478 | volume | 78 |
| Q47768599 | A gut lipid messenger links excess dietary fat to dopamine deficiency |
| Q87076295 | A role for oleoylethanolamide in chronic lymphocytic leukemia |
| Q30372594 | Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. |
| Q33758242 | CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice |
| Q38545827 | Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals? |
| Q91610296 | Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol |
| Q35089784 | Current and future drug targets in weight management |
| Q35839688 | Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice |
| Q35193895 | Dietary non-esterified oleic Acid decreases the jejunal levels of anorectic N-acylethanolamines |
| Q33846570 | Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients |
| Q64093515 | Dynamic changes of key metabolites during liver fibrosis in rats |
| Q90556278 | Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats |
| Q40794240 | Endocannabinoids and the processing of value-related signals |
| Q38262627 | Fat sensing and metabolic syndrome |
| Q37785382 | Fatty acid amide signaling molecules |
| Q46021580 | Fatty acid ethanolamides modulate CD36-mRNA through dietary fatty acid manipulation in Syrian Golden hamsters. |
| Q90923277 | First evidence on the role of palmitoylethanolamide in energy homeostasis in fish |
| Q36353394 | Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues |
| Q37794210 | Gastrointestinal targets to modulate satiety and food intake |
| Q92917437 | Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa |
| Q33944259 | Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity |
| Q28258759 | Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice |
| Q47390763 | Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. |
| Q47862279 | Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D. |
| Q55141706 | Long Chain n-3 Fatty Acids Improve Depression Syndrome in Type 2 Diabetes Mellitus. |
| Q37382374 | Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring. |
| Q41894976 | Membrane-mediated action of the endocannabinoid anandamide on membrane proteins: implications for understanding the receptor-independent mechanism. |
| Q34328745 | Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways |
| Q27664193 | Modulation of Pantothenate Kinase 3 Activity by Small Molecules that Interact with the Substrate/Allosteric Regulatory Domain |
| Q34565304 | Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans |
| Q27011679 | N-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leads |
| Q36744621 | N-Acylethanolamines Bind to SIRT6 |
| Q50074099 | Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour. |
| Q37717854 | Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite |
| Q28390536 | Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide |
| Q33569699 | Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats |
| Q60714197 | Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia |
| Q38157791 | Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. |
| Q21285123 | Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold |
| Q27322965 | Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide/endocannabinoid signaling system associated to memory impairments in postweaned rats. |
| Q92097819 | Physiology of the Endocannabinoid System During Development |
| Q39875770 | Pitfalls in the sample preparation and analysis of N-acylethanolamines |
| Q33952044 | Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women |
| Q37105737 | Quantitative analysis of N-acylphosphatidylethanolamine molecular species in rat brain using solid-phase extraction combined with reversed-phase chromatography and tandem mass spectrometry |
| Q38119472 | Quantitative metabolic profiling of lipid mediators. |
| Q42232533 | Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers |
| Q47280730 | Secretion, isotopic labeling and deglycosylation of N-Acylethanolamine acid amidase for biophysical studies |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q38040181 | The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity |
| Q37513684 | Upper intestinal lipids regulate energy and glucose homeostasis |
Search more.